Showing results (311-320 of 396) with videos related to

Sort By:
Pageof 40
Cancer Medicine|March 21, 2022
A WIN Consortium phase I study exploring avelumab, palbociclib, and axitinib in advanced non-small cell lung cancerBenjamin Solomon, Ana Callejo, Jair Bar, et al.
Lung Cancer (Amsterdam, Netherlands)|May 24, 2022
Molecular profiling of non-small-cell lung cancer patients with or without brain metastases included in the randomized SAFIR02-LUNG trial and association with intracranial outcomeAlice Mogenet, Fabrice Barlesi, Benjamin Besse, et al.
European Journal of Cancer (Oxford, England : 1990)|October 19, 2013
Primary cardiac sarcomas: a retrospective study of the French Sarcoma GroupNicolas Isambert, Isabelle Ray-Coquard, Antoine Italiano, et al.
Oncotarget|April 23, 2021
High <i>in vitro</i> and <i>in vivo</i> synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLCElodie Montaudon, Rania El Botty, Sophie Vacher, et al.
The Journal of Pathology|September 27, 2024
DNA methylation as a new tool for the differential diagnosis between T-LBL and lymphocyte-rich thymomaMehdi Latiri, Mohamed Belhocine, Charlotte Smith, et al.
European Journal of Cancer (Oxford, England : 1990)|July 19, 2024
Sotorasib (960 mg or 240 mg) once daily in patients with previously treated KRAS G12C-mutated advanced NSCLCMaximilian J Hochmair, Karim Vermaelen, Giannis Mountzios, et al.
British Journal of Cancer|September 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosisAbderaouf Hamza, Pierre Gestraud, Maryam Karimi, et al.
Science Immunology|February 3, 2023
Noncanonical splicing junctions between exons and transposable elements represent a source of immunogenic recurrent neo-antigens in patients with lung cancerAntonela Merlotti, Benjamin Sadacca, Yago A Arribas, et al.
Future Oncology (London, England)|April 6, 2026
SUNRAY-01 trial protocol: an innovative study design of olomorasib and pembrolizumab with or without chemotherapy in <i>KRAS</i> G12C NSCLCSolange Peters, Maximilian Hochmair, Kathryn C Arbour, et al.
Lung Cancer (Amsterdam, Netherlands)|September 27, 2023
Long-term effectiveness and treatment sequences in patients with extensive stage small cell lung cancer receiving atezolizumab plus chemotherapy: Results of the IFCT-1905 CLINATEZO real-world studyLionel Falchero, Florian Guisier, Marie Darrason, et al.
Pageof 40